MNPR

Monopar Therapeutics Inc

• TipRanks·4d ago

  Monopar Therapeutics Inc (MNPR) Gets a Buy from JonesTrading

• TipRanks·03/30 13:37

  Monopar Therapeutics Inc (MNPR) Receives a Buy from Lake Street

• Dow Jones·03/30 12:10

  Monopar Therapeutics Is Maintained at Buy by Chardan Capital

• Dow Jones·03/30 12:10

  Monopar Therapeutics Price Target Maintained With a $100.00/Share by Chardan Capital

• TipRanks·03/30 10:30

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Illumina (ILMN), Kyverna Therapeutics, Inc. (KYTX) and Monopar Therapeutics Inc (MNPR)

• TipRanks·03/30 10:05

  Buy Rating Reaffirmed on ALXN1840 De‑Risking, 2027 Approval Potential, and Strong Cash Runway

• TipRanks·03/30 07:30

  Wall Street Analysts Are Bullish on Top Healthcare Picks

• Seeking Alpha·03/27 20:47

  Monopar Therapeutics GAAP EPS of -$0.61 misses by $0.16

• Reuters·03/27 17:18

  Monopar Therapeutics Q4 net loss narrows on lower R&D costs

• Benzinga·03/27 17:06

  Monopar Therapeutics Q4 EPS $(0.61) Misses $(0.54) Estimate

• Reuters·03/27 17:01

  Monopar Therapeutics FY2025 net loss narrows 12% to $(13.7) million; interest income jumps more than 6x to $3.0 million

• Dow Jones·03/27 17:01

  *Monopar Therapeutics 4Q Loss/Shr 61c >MNPR

• Dow Jones·03/27 17:00

  Press Release: Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

• Reuters·03/04 22:25

  Monopar Therapeutics files initial beneficial ownership statement for CCSO Susan Rodriguez

• TipRanks·03/02 13:38

  Monopar Appoints Chief Commercial and Strategy Officer Rodriguez